Document Detail


Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure.
MedLine Citation:
PMID:  18482434     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
During puberty, neuronal maturation of the brain, which began during perinatal development, is completed such that the behavioral potential of the adult organism can be fully achieved. These maturational events and processes of reorganization are needed for the occurrence of adult behavioral performance but simultaneously render the organism highly susceptible to perturbations, such as exposure to psychoactive drugs, during this critical developmental time span. Considering the variety of maturational processes occurring in the endocannabinoid system during this critical period, it is not surprising that the still-developing brain might by highly susceptible to cannabis exposure. Emerging evidence from human studies and animal research demonstrates that an early onset of cannabis consumption might have lasting consequences on cognition, might increase the risk for neuropsychiatric disorders, promote further illegal drug intake and increase the likelihood of cannabis dependence. These findings suggest that young people represent a highly vulnerable cannabis consumer group and that they run a higher risk than adult consumers of suffering from adverse consequences from cannabinoid exposure. The aim of the present review is to provide an overview over the possible deleterious residual cannabinoid effects during critical periods of postnatal maturation and to offer a more precise delineation of the vulnerable time window for cannabinoid exposure.
Authors:
Miriam Schneider
Related Documents :
11750784 - The impact of prenatal stress, fetal alcohol exposure, or both on development: perspect...
17363194 - Hazardous alcohol users during pregnancy: psychiatric health and personality traits.
15309404 - Labor analgesia for the tobacco and ethanol abusing pregnant patient: a routine managem...
15084904 - Effect of duration of maternal alcohol consumption on calcium metabolism and bone in th...
12848444 - Human chorionic gonadotropin testing for early pregnancy viability and complications.
16466394 - Sex reversal in medaka treated in vitro with 17alpha-methyldihydrotestosterone during o...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Addiction biology     Volume:  13     ISSN:  1369-1600     ISO Abbreviation:  Addict Biol     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2008-05-16     Completed Date:  2008-07-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9604935     Medline TA:  Addict Biol     Country:  England    
Other Details:
Languages:  eng     Pagination:  253-63     Citation Subset:  IM    
Affiliation:
Central Institute of Mental Health (ZI), Department of Psychopharmacology, Mannheim, Germany. miriam.schneider@zi-mannheim.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Animals
Brain / drug effects*,  physiopathology
Cannabinoids / toxicity*
Child
Cognition Disorders / chemically induced*,  physiopathology,  psychology
Drug Tolerance
Endocannabinoids / metabolism*
Humans
Marijuana Abuse / physiopathology*,  psychology
Neurons / drug effects,  physiology
Neuropsychological Tests
Psychoses, Substance-Induced / physiopathology*,  psychology
Puberty / drug effects*,  physiology*
Receptor, Cannabinoid, CB1 / drug effects*,  physiology*
Risk Factors
Substance-Related Disorders / physiopathology,  psychology
Tetrahydrocannabinol / toxicity
Chemical
Reg. No./Substance:
0/Cannabinoids; 0/Endocannabinoids; 0/Receptor, Cannabinoid, CB1; 1972-08-3/Tetrahydrocannabinol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clini...
Next Document:  Cannabis and psychiatric disorders: it is not only addiction.